NCT01652768

Brief Summary

The purpose of this pilot study is to investigate the feasibility of an early palliative care intervention (PRESENCE: Providing Resources Education, Support, and Enabling New brain tumor patients to Cope Effectively) and the effect of the intervention on patient and caregiver distress.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2011

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2011

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

July 26, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 30, 2012

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2013

Completed
Last Updated

August 29, 2013

Status Verified

August 1, 2013

Enrollment Period

1.7 years

First QC Date

July 26, 2012

Last Update Submit

August 28, 2013

Conditions

Keywords

Malignant Brain TumorsMalignant GliomaHigh-grade GliomasOncologyCancerPatient CaregiverCaregiver Stress, Anxiety, DepressionPalliative Care Intervention

Outcome Measures

Primary Outcomes (1)

  • Feasibility of the intervention will be measured by participant surveys.

    Using the patient satisfaction tool, the researchers will report descriptive data on patient and caregiver satisfaction with the intervention and any burden associated with participating in the intervention. In addition, the ability to contact patients and caregivers on an every two week basis, patient and caregiver attendance at the educational program, and evaluations from the Moving Forward program will be tracked.

    10 weeks

Secondary Outcomes (5)

  • Change in distress level

    10 weeks

  • Change in Anxiety level

    10 weeks

  • Change in Depression level

    10 weeks

  • Caregiver Response to the Caregiving Experience

    10 weeks

  • Caregiver Mastery

    10 weeks

Study Arms (2)

Arm A: Usual Care Group

ACTIVE COMPARATOR

Usual care is defined as standard post-operative care on a surgical unit in University Hospitals Case Medical Center. Discharge planning will be provided by the assigned in-patient social worker. Referrals to the assigned outpatient social worker will be made as appropriate. Patients and caregivers will be seen in the ambulatory medical oncology setting about three to six weeks after surgery, depending on post-operative recovery time. The research assistant will administer the research questionnaires at week one post-surgery and 8-10 weeks post surgery.

Other: Research Questionnaires

Arm B: PRESENCE Intervention

EXPERIMENTAL

The unique features of the PRESENCE Project (PP) Intervention are 1) the early palliative care intervention (immediately post-op) provided by the new palliative care brain tumor team (Social worker, advanced practice nurse (APN), medical oncology registered nurse); 2) an educational information session for patients and caregivers; and 3) frequent (every two week and as needed) telephone or clinic visits during the first ten weeks post operatively (Figure 1). In usual care, the patient and caregiver receive little supportive care until they begin cancer treatment. The intervention provides aggressive supportive care from the time of diagnosis.

Other: Research QuestionnairesOther: Palliative Care TeamOther: Educational Information Session for Patients and CaregiversOther: Contact every 2 weeksOther: Follow-up Surgical Visit SessionOther: Medical and/or Radiation Oncology Appointment Session

Interventions

Hospital Anxiety and Depression Scale Pearlin \& Schooler Caregiver Mastery Caregiver Assessment Tool Patient/Caregiver Satisfaction Survey

Arm A: Usual Care GroupArm B: PRESENCE Intervention

Week 1: Early palliative care intervention (immediately post-op) provided by the new palliative care brain tumor team (Social worker, advanced practice nurse (APN), medical oncology registered nurse). 1. Introduce the palliative care team concept. 2. Provide contact information for the palliative care team given 3. Administer Initial Patient and Caregiver Psychosocial Assessments (Appendix A) 4. Offer community resources to patient and caregiver (Appendix B) 5. Provide additional resources/referrals for any needs that are identified by patient or care partner during initial psychosocial assessment 6. Provide supportive care

Arm B: PRESENCE Intervention

Provide an educational class "Moving Forward: Facing a Brain Tumor Diagnosis" for patient and caregiver Week 5 through 7: The PRESENCE Project Social Worker and oncology RN will provide an educational class. Intervention (Length of time for class = 2 hours): 1. Provide an educational class "Moving Forward: Facing a Brain Tumor Diagnosis" for patient and caregiver. 2. Provide additional resources/referrals for any needs that are identified by patient or care partner during the educational class. 3. Provide supportive care.

Arm B: PRESENCE Intervention

The PRESENCE Project APN and/or Presence Project Social Worker will contact the patient and caregiver via telephone or office visit every two weeks and as needed until the second medical oncology visit. (Anticipated length of time for phone intervention or visit is 20 minutes; however, length of time for intervention is tailored to the patient and caregiver's needs): 1. Administer Patient and Caregiver Follow-up Assessment 2. Provide pain and/or symptom management intervention for any issues identified during the follow-up assessment 3. Provide resources/referrals for any needs identified during the social work follow-up assessment 4. Provide supportive care

Arm B: PRESENCE Intervention

The PRESENCE Project APN will meet with patient and caregiver at the surgical follow-up visit, approximately two weeks after surgery. Intervention (Anticipated length of time for visit is about 30 minutes; however length of time for intervention is tailored to the patient and caregiver's needs): 1. Administer Patient and Caregiver Follow-up Assessment 2. Administer Symptom Assessment Tool 3. Provide pain and/or symptom management intervention 4. Provide supportive care

Arm B: PRESENCE Intervention

The PRESENCE Project APN and/or Presence Project Social Worker will meet with patient and caregiver at the first medical and/or radiation oncology appointment (weeks 3 and 4). Intervention (Anticipated length of time for visit is about 30 minutes; however length of time for intervention is tailored to the patient and caregiver's needs): 1. Administer Patient and Caregiver Follow-up Assessment 2. Re-assess pain and/or symptom management issues and /or intervention 3. Provide resources/referrals for any needs identified during the social work follow-up assessment 4. Provide supportive care.

Arm B: PRESENCE Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • are identified by the patient and/or caregiver as the "primary caregiver"
  • were involved in caregiving during the first ten weeks following diagnosis at the SCC
  • are capable of providing informed consent.

You may not qualify if:

  • \- include those whose are caring for patients who are in hospice or within 2 months of death, as this experience may influence their recollection of the diagnosis phase of the cancer trajectory.
  • are newly diagnosed malignant brain tumor patients who are at University Hospitals and who are within a week of surgery
  • are receiving on-going care at the Seidman Cancer Center
  • are able to identify a primary caregiver involved in their care, support, and/or care planning
  • are capable of providing informed consent.
  • \- are those with a life expectancy of less than two months and/or those who are electing hospice care who will be receiving medical and or radiation oncology care outside of the Seidman Cancer Center.
  • Eligibility criteria for caregivers (Phase II)
  • being identified by the patient as the "primary caregiver"
  • capable of providing informed consent.
  • Both the patient and caregiver must consent to be in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center

Cleveland, Ohio, 44106, United States

Location

MeSH Terms

Conditions

GliomaNeoplasmsCaregiver BurdenAnxiety DisordersDepression

Interventions

Caregivers

Condition Hierarchy (Ancestors)

Neoplasms, NeuroepithelialNeuroectodermal TumorsNeoplasms, Germ Cell and EmbryonalNeoplasms by Histologic TypeNeoplasms, Glandular and EpithelialNeoplasms, Nerve TissueStress, PsychologicalBehavioral SymptomsBehaviorMental Disorders

Intervention Hierarchy (Ancestors)

Health PersonnelHealth Care Facilities Workforce and Services

Study Officials

  • Polly Mazanec, PhD

    Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 26, 2012

First Posted

July 30, 2012

Study Start

December 1, 2011

Primary Completion

August 1, 2013

Study Completion

August 1, 2013

Last Updated

August 29, 2013

Record last verified: 2013-08

Locations